CLinical Prediction Rule Score in Veterans
NCT01418781 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2024-03-13
Summary
We will study whether the health care costs and health utilities differ in patients with gout and those without gout and whether they differ between those with more severe versus less severe gout
Conditions
Sponsors & Collaborators
-
Birmingham, Alabama VA Medical Center
collaborator FED - collaborator INDUSTRY
- collaborator INDUSTRY
- collaborator INDUSTRY
-
jasvinder singh
lead FED
Principal Investigators
-
David Nelson · Minneapolis VAMC
Eligibility
- Min Age
- 18 Years
- Max Age
- 110 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-01-31
- Primary Completion
- 2010-03-31
- Completion
- 2010-03-31
Countries
- United States
Study Locations
More Related Trials
-
Center of Research Translation (CORT) Project 2
NCT02038179 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
MRI and Ultrasound Findings in Patients With Gout and Normal Plain Radiographs
NCT00584311 ·Status: COMPLETED ·Phase: NA
-
Musculoskeletal Ultrasound in Asymptomatic Hyperuricemia
NCT02502565 ·Status: UNKNOWN
-
The Blood Pressure Effects of Febuxostat in Patients Previously Treated With Allopurinol: A Pilot Study
NCT01701622 ·Status: TERMINATED ·Phase: NA
-
Relation Between Blood Concentration of Colchicine and Response to Colchicine Treatment in Gout Flare
NCT03933007 ·Status: TERMINATED ·Phase: PHASE4
-
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
NCT01459796 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of the Efficacy of Genakumab in Prevention of Acute Flares in Gout Patients Initiating Urate-lowering TherapyUrate-lowering (GenSci048-202)
NCT05936281 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating the Effectiveness of a Chronic Disease Management Program for Gout
NCT01568879 ·Status: COMPLETED ·Phase: NA
-
Assessing the Role of the NLRP3 Inflammasome in Intercritical Gout
NCT04125459 ·Status: ACTIVE_NOT_RECRUITING
-
Uric Acid and the Endothelium in CKD
NCT01228903 ·Status: COMPLETED ·Phase: NA
-
Effect of Febuxostat on Joint Damage in Hyperuricemic Subjects With Early Gout
NCT01078389 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled Gout
NCT03635957 ·Status: COMPLETED ·Phase: PHASE4
-
Imagery as Biomarker of Gout
NCT05434858 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Prospective Cohort Study of China Serum Uric Acid Levels
NCT03616769 ·Status: COMPLETED
-
Low-dose Colchicine With or Without Stepwise Dose Titration of Febuxostat for Flare Prophylaxis in Gout
NCT04697602 ·Status: TERMINATED ·Phase: NA
-
DECT Study in Allopurinol-Treated Gout Patients
NCT02393560 ·Status: COMPLETED
-
Study of URC102 to Assess the Safety and Efficacy in Gout Patients
NCT02557126 ·Status: COMPLETED ·Phase: PHASE2
-
Allopurinol in Acute Gout
NCT01775098 ·Status: WITHDRAWN ·Phase: NA
-
Initiation of Allopurinol at First Medical Contact for Acute Attacks of Gout
NCT01310673 ·Status: COMPLETED ·Phase: PHASE4
-
Arthritis Research UK Gout Treatment Trial - Phase 2
NCT01477346 ·Status: COMPLETED ·Phase: NA
-
Study of Febuxostat Effect on Blood Pressure in Patients With High Normal Blood Pressure
NCT01472692 ·Status: COMPLETED ·Phase: PHASE4
-
A Nurse Led Patient Management Programme to Improve Outcomes in Gout
NCT03345186 ·Status: COMPLETED ·Phase: NA
-
the Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or More
NCT06622603 ·Status: RECRUITING ·Phase: PHASE4
-
Efficacy and Safety of Colchicine for the Prevention of Gout Flares During the Initiation of Allopurinol
NCT01451645 ·Status: COMPLETED ·Phase: PHASE4
-
Gender Differences in the Metabolic Effects of Uric Acid
NCT03076684 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1